Clinicians prescribing a drug for patients with multiple sclerosis who are on multiple treatments may in future use AI to identify potential interactions and suggest safer options, new data suggest.
The relapse benefit of ocrelizumab in multiple sclerosis is confirmed for the first time in patients 60 and older starting therapy, say researchers in findings they hope will inform choices.
Delirium, known as a type of brain dysfunction marked by abrupt bouts of confusion, paranoia, inattention, or even agitation and hallucinations has been developed by over one-third of all people who had been admitted to the hospital and as many as 80% of all patients in an intensive care unit (ICU).
Johns Hopkins Searches for AI to Predict Risk of ICU Delirium miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Johns Hopkins Creates AI to Predict ICU Delirium Risk miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.